Vicore Pharma is

A drug-development company at the international cutting edge of research on the AT2 receptor. The company's portfolio contains small molecules with potential indications including anti-inflammation, nerve generation and cardiovascular disease. Our vision is to lead the development of new molecules with agonistic action to the AT2 receptor into successful clinical drug entities. 

News

Vicore Pharma Holding utökar innehav i I-Tech2016-07-28Delårsrapport jan-jun 20162016-07-08Show more news

The AT2 receptor

The AT2 receptor is expressed and activated in the fetus where it supports organ development and differention, and in damaged adult tissue where it restitutes morphology and function, restores heart function after myocardial infarction, reduces inflammation, regenerates neural tissue - to mention but a few of the beneficial effects.

Calender

BioPharm America 20162016-09-13 - 2016-09-15Boston NLS days2016-09-14 - 2016-09-15Stockholm waterfront, Stockholm Show more events